French ceramic femoral head producer receives compensation demands
This article was originally published in Clinica
Saint-Gobain Ceramiques Avancees Desmarquest, the manufacturer of the defective zirconium ceramic femoral heads, has received 45 demands for compensation from patients, 20 from patients in Europe and 25 from the US. But this may just be the tip of the iceberg, say the national press, as the French company has manufactured and sold some half a million of these products. Clinica was unable to obtain comment at time of going to press.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.